• Home
  • About
    • Mission & Overview
    • Our Team
    • Strategic Advisory Council
    • Veterans Advisory Council
    • Board of Directors
  • Brain Health
    • About Post-Traumatic Stress
    • About Traumatic Brain Injury
    • Patient & Veteran Perspectives
  • Programs
    • Our Programs
    • Roadmap
    • Advocacy
    • Publications & Resources
    • BRAIN Commons
    • Funding Opportunities
    • Legacy Programs
      • Multiple Sclerosis
      • – Orion MS 1.0
      • Biomarkers
      • – Resources
  • The Alliance
    • Cooperative Bionetwork
    • Our Sponsors
    • Our Partners
  • News & Events
    • News
    • Events
    • Webinars
    • Press
    • Newsletter
    • 22 Jumps
    • State of the Science Summit
    • Cohen Veterans Care Summit
  • Careers
  • Donate
  • Contact
Cohen Veterans Bioscience Cohen Veterans Bioscience
  • Home
  • About
    • Mission & Overview
    • Our Team
    • Strategic Advisory Council
    • Veterans Advisory Council
    • Board of Directors
  • Brain Health
    • About Post-Traumatic Stress
    • About Traumatic Brain Injury
    • Patient & Veteran Perspectives
  • Programs
    • Our Programs
    • Roadmap
    • Advocacy
    • Publications & Resources
    • BRAIN Commons
    • Funding Opportunities
    • Legacy Programs
      • Multiple Sclerosis
      • – Orion MS 1.0
      • Biomarkers
      • – Resources
  • The Alliance
    • Cooperative Bionetwork
    • Our Sponsors
    • Our Partners
  • News & Events
    • News
    • Events
    • Webinars
    • Press
    • Newsletter
    • 22 Jumps
    • State of the Science Summit
    • Cohen Veterans Care Summit
  • Careers
  • Donate
  • Contact

News

Cohen Veterans Bioscience > News
  • Dr. Andreas Jeromin Leading Panel on Identifying Biological Markers of Posttraumatic Stress Disorder at ISTSS 36th Annual Meeting, November 4-14

    November 4, 2020

    Our Chief Scientific Officer Dr. Andreas Jeromin is leading a panel discussion at the ISTSS 37th Annual Meeting, titled “Identifying Biological Markers of Posttraumatic Stress Disorder (PTSD): Recent Findings and Efforts Across Modalities to Enhance Rigor and Robustness”.

    Read more
  • Quote from Dr. Andreas Jeromin

    New Research Partnership Pushes for Increased Transparency & Publication of Negative Research

    November 2, 2020

    Null Hypothesis is a collaborative initiative dedicated to publishing well-performed replication and negative studies — or studies where the outcomes do not confirm expected results or working hypotheses — via dedicated journal space.

    Read more
  • Quote from Dr. Magali Haas

    Neuron-Based Gene Expression Study Reveals Insights on Fear and Its Regulation

    October 30, 2020

    We’re proud to support a new study with our partner McLean Hospital exploring how the expression of a gene may function as a switch to regulate feelings of fear in psychiatric illnesses such as Post-Traumatic Stress Disorder (PTSD).

    Read more
  • Join CVB and other researchers and clinicians at the virtual 10th Annual Traumatic Brain Injury Conference

    October 27, 2020

    Our Chief Scientific Officer, Dr. Andreas Jeromin, is Chairing the conference on November 2-4, 2020 and will be joined by the CVB leadership team. Dr. Jeromin will be discussing recommendations from the Brain Trauma Blueprint 2019 State of the Science Summit.

    Read more
  • CNS Summit

    Cohen Veterans Bioscience Virtually Attending & Exhibiting at the 2020 CNS Summit

    October 23, 2020

    We are excited to virtually attend and exhibit at the 2020 CNS Summit, October 29 – November 1, 2020.

    This annual event convenes innovators across industry, academia, media, non-profit organizations, and others to enable networking, discussion, and collaboration in clinical development.

    Read more
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • ...
  • 43
  • Next
Help Us Make Brain Disorders Predictable, Treatable & Curable
WHO WE ARE
Cohen Veterans Bioscience is a nonprofit 501(c)(3) research organization dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of Veterans and civilians who suffer the devastating effects of trauma-related and other brain disorders.
Learn More Donate
LEARN MORE ABOUT OUR MISSION
Get News & Updates

Get Email Updates

GuideStar 2019 Silver Seal of Transparency

©2021 Cohen Veterans Bioscience
Powered by Tone Creative

  • Privacy Policy
  • Terms of Use
  • Indirect Cost Policy
  • Careers
  • Contact Us
  • Donate